Israel Englander’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.59M | Sell |
320,910
-80,909
| -20% | -$1.37M | ﹤0.01% | 2729 |
|
|
2026
Q1 | $6.39M | Sell |
401,819
-537,556
| -57% | -$11.7M | ﹤0.01% | 2669 |
|
|
2025
Q4 | $24.7M | Sell |
939,375
-529,469
| -36% | -$13.7M | 0.01% | 1371 |
|
|
2025
Q3 | $33.2M | Buy |
1,468,844
+26,582
| +2% | +$547K | 0.01% | 1177 |
|
|
2025
Q2 | $28.7M | Sell |
1,442,262
-527,171
| -27% | -$10.3M | 0.01% | 1241 |
|
|
2025
Q1 | $33.3M | Buy |
1,969,433
+437,632
| +29% | +$7.45M | 0.02% | 1074 |
|
|
2024
Q4 | $28.3M | Buy |
1,531,801
+261,152
| +21% | +$5.1M | 0.01% | 1224 |
|
|
2024
Q3 | $27.6M | Buy |
1,270,649
+311,797
| +33% | +$6.97M | 0.01% | 1269 |
|
|
2024
Q2 | $18.8M | Buy |
958,852
+244,981
| +34% | +$5.11M | 0.01% | 1553 |
|
|
2024
Q1 | $15.5M | Buy |
713,871
+349,143
| +96% | +$8.67M | 0.01% | 1768 |
|
|
2023
Q4 | $10.5M | Buy |
364,728
+333,299
| +1,060% | +$8.92M | ﹤0.01% | 2132 |
|
|
2023
Q3 | $840K | Buy |
31,429
+5,622
| +22% | +$192K | ﹤0.01% | 4301 |
|
|
2023
Q2 | $956K | Sell |
25,807
-25,820
| -50% | -$900K | ﹤0.01% | 4078 |
|
|
2023
Q1 | $1.61M | Buy |
51,627
+21,259
| +70% | +$684K | ﹤0.01% | 3640 |
|
|
2022
Q4 | $904K | Sell |
30,368
-92,100
| -75% | -$3.3M | ﹤0.01% | 4267 |
|
|
2022
Q3 | $4.67M | Buy |
122,468
+72,893
| +147% | +$3.65M | ﹤0.01% | 2954 |
|
|
2022
Q2 | $2.7M | Sell |
49,575
-231,361
| -82% | -$12.7M | ﹤0.01% | 3398 |
|
|
2022
Q1 | $17.5M | Buy |
280,936
+278,201
| +10,172% | +$18.3M | 0.01% | 1531 |
|
|
2021
Q4 | $275K | Sell |
2,735
-6,803
| -71% | -$598K | ﹤0.01% | 5633 |
|
|
2021
Q3 | $858K | Sell |
9,538
-5,031
| -35% | -$457K | ﹤0.01% | 4848 |
|
|
2021
Q2 | $1.34M | Sell |
14,569
-62,031
| -81% | -$4.95M | ﹤0.01% | 4381 |
|
|
2021
Q1 | $7.4M | Buy |
76,600
+17,982
| +31% | +$1.86M | 0.01% | 2128 |
|
|
2020
Q4 | $3.05M | Sell |
58,618
-24,897
| -30% | -$1.04M | ﹤0.01% | 2882 |
|
|
2020
Q3 | $3.34K | Sell |
83,515
-16,255
| -16% | -$509K | ﹤0.01% | 2182 |
|
|
2020
Q2 | $1.6M | Buy |
99,770
+51,207
| +105% | +$784K | ﹤0.01% | 2689 |
|
|
2020
Q1 | $523K | Buy |
+48,563
| New | +$676K | ﹤0.01% | 2851 |
|
|
2017
Q3 | – | Sell |
-14,619
| Closed | -$93K | – | 3611 |
|
|
2017
Q2 | $93K | Buy |
14,619
+3,625
| +33% | +$29.2K | ﹤0.01% | 3306 |
|
|
2017
Q1 | $120K | Sell |
10,994
-12,207
| -53% | -$144K | ﹤0.01% | 3302 |
|
|
2016
Q4 | $268K | Sell |
23,201
-65,313
| -74% | -$616K | ﹤0.01% | 2957 |
|
|
2016
Q3 | $816K | Buy |
+88,514
| New | +$814K | ﹤0.01% | 2374 |
|
Other funds holding FLGT
DC
Israel Englander's FLGT Position: Q2 2026 in Review
Israel Englander reduced its Fulgent Genetics (FLGT) stake by 20% in Q2 2026, selling an estimated $1.37M and leaving 320,910 shares worth $6.59M. The position accounts for ﹤0.01% of the portfolio, ranked #2729.
Israel Englander first reported a position in FLGT in Q3 2016 and has held it in 30 quarters since. The position peaked at $33.3M in Q1 2025. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.
- Israel Englander held 320,910 shares of Fulgent Genetics worth $6.59M as of Q2 2026.
- Israel Englander sold 80,909 Fulgent Genetics shares in Q2 2026, an estimated $1.37M.
- Fulgent Genetics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2729 holding.
- Israel Englander first reported a position in Fulgent Genetics in Q3 2016 and has held it in 30 quarters since.
- Israel Englander's Fulgent Genetics position peaked at $33.3M in Q1 2025.
- 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.